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The intestinal epithelial cells (IECs) that line the
gut form a robust line of defense against ingested
pathogens. We investigated the impact of infection
with the enteric pathogen Citrobacter rodentium on
mouse IEC metabolism using global proteomic and
targeted metabolomics and lipidomics. The major
signatures of the infection were upregulation of the
sugar transporter Sglt4, aerobic glycolysis, and pro-
duction of phosphocreatine, which mobilizes cyto-
solic energy. In contrast, biogenesis of mitochondrial
cardiolipins, essential for ATP production, was in-
hibited, which coincided with increased levels of
mucosal O2 and a reduction in colon-associated
anaerobic commensals. In addition, IECs responded
to infection by activating Srebp2 and the cholesterol
biosynthetic pathway. Unexpectedly, infected IECs
also upregulated the cholesterol efflux proteins
AbcA1, AbcG8, and ApoA1, resulting in higher levels
of fecal cholesterol and a bloom of Proteobacteria.
These results suggest thatC. rodentiummanipulates
host metabolism to evade innate immune responses
and establish a favorable gut ecosystem.
INTRODUCTION
The intestinal epithelium is comprised of LGR5+ stem cells at the
base of the crypt, proliferating transit-amplifying (TA) cells at the
lower part of the crypt and a monolayer of columnar intestinal
epithelial cells (IECs) that are renewed every 5–7 days (Barker,
2014). The proliferating crypt cells are believed to utilize aerobic
glycolysis (the Warburg effect) by fermenting glucose to lactate
(Koppenol et al., 2011).
The IECs play a key role in absorption and systemic dispersion
of electrolytes, nutrients, and water from the lumen of the gut738 Cell Metabolism 26, 738–752, November 7, 2017 ª 2017 The Au
This is an open access article under the CC BY license (http://creative(Peterson and Artis, 2014). IECs also form a robust line of host
defense against ingested pathogens, acting as a physical barrier
and through detection of pathogen-associated molecular pat-
terns via pattern recognition receptors, such as toll-like recep-
tors (TLRs) 2 and TLR4 (Peterson and Artis, 2014). As such, the
pathogen-IEC interface constitutes the battle line between the
host innate immune system and the pathogen’s counteracting
virulence factors.
IECs have a high-energy demand and their extensive anabolic
activity relies on various sources of energy. Glucose, glutamine,
glutamate, and aspartate are delivered to IECs through the circu-
latory system (Blachier et al., 2017), while the short-chain fatty
acids (SCFAs) acetate, propionate, and butyrate are absorbed
directly from the gut lumen, where they are produced by the
microbiota through fermentation of dietary fiber and amino acids
(Neis et al., 2015). Butyrate, which in the colon is absorbed
mainly via the monocarboxylate transporter 1 (Mct1), is pro-
cessed via b-oxidation and feeds the tricarboxylic acid (TCA) cy-
cle and oxidative phosphorylation in the mitochondria (Donohoe
et al., 2011). Despite the growing appreciation of the role subver-
sion of cellular metabolism plays during host-pathogen interac-
tions (Fuchs et al., 2012), our understanding of changes to the
metabolic networks of host cells during infection, particularly
IECs, is incomplete.
Citrobacter rodentium is an extracellular, mouse-specific,
pathogen that intimately binds the apical surface of IECs and
triggers effacement of the brush border (BB) microvilli, forming
attaching and effacing lesions, in a similar manner to entero-
pathogenic and enterohemorrhagic Escherichia coli (EPEC and
EHEC) (Mundy et al., 2005). Moreover, by inducing extensive
amplification of TA cells and inhibiting anoikis and cell detach-
ment, C. rodentium induces colonic crypt hyperplasia (CCH)
(Collins et al., 2014).
Following oral inoculation C. rodentium first resides in the
cecum, before colonization spreads to the entire colonicmucosa
(Wiles et al., 2004). Bacterial shedding peaks around 8 days post
infection (DPI) and the infection starts to clear at around 12 DPI.
Injection of bacterial effector proteins via a type III secretion
system (T3SS) into IECs is the key mechanism by which ofthor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
C. rodentium establishes infection at the epithelial surface
(Mundy et al., 2005). Once in the host cytosol these effectors
take control of key cell signaling processes, including
actin dynamics, endosomal trafficking, and apoptosis (Wong
et al., 2011).
The inflammatory nature of the infection means that
C. rodentium interactions with IECs take place in an environment
rich in cytokines (e.g., interleukin-18 [IL-18], IL-22, IL-6, IL-1b, tu-
mor necrosis factor alpha [TNF-a], interferon-g) and infiltrating
immune cells (Collins et al., 2014). Consequently, infected IECs
respond to the inflammatory signals in the gut by expressing
high levels of antimicrobial peptides (Collins et al., 2014) and api-
cal inducible nitric oxide synthase (iNOS), capable of producing
nitric oxide (NO) to which C. rodentium is sensitive (Lopez et al.,
2016; Vallance et al., 2002). Indeed, one well-characterized
function of the T3SS effectors is the subversion of innate immune
responses in IECs, e.g., nuclear factor kB [NF-kB] and c-Jun
N-terminal kinase (Pearson et al., 2016) and the non-canonical
caspase-4/11 inflammasome (Pallett et al., 2017). In addition,
T3SS effectors also target mitochondrial functions. The effector
Map, which acts as a guanine nucleotide exchange factor for
Cdc42 (Huang et al., 2009), is targeted to the mitochondria
where it induces disruption of the mitochondrial morphology
and loss of mitochondrial respiratory functions (Ma et al.,
2006). How the pathogen benefits from altering the function of
the mitochondria, and thus the production and flow of energy
in infected IECs, remains unknown.
In this study we conducted the first in-depth proteomics anal-
ysis of IECs isolated from mice infected with C. rodentium and
reveal extensive remodeling of metabolic pathways during infec-
tion. We subsequently confirmed these findings using targeted
assays.We show thatC. rodentium infection results in significant
dampening of central carbon metabolism in IECs, particularly
production of mitochondrial cardiolipins. This coincided with
elevated levels of O2 above the infected IECs, confirming a pre-
vious report showing that C. rodentium favors oxidative meta-
bolism in vivo (Lopez et al., 2016). Uniquely, we found that in-
fected IECs upregulate cholesterol biogenesis, which was
unusually accompanied by upregulation of the cholesterol efflux
transporter Abca1 and AbcG8, as well as ApoA1, leading to
elevated levels of fecal cholesterol. Finally, the infection-induced
increase in luminal O2 and cholesterol were reflected by the
observed dysbiosis triggered by C. rodentium infection.
RESULTS
C. rodentium Disrupts Host Metabolic Processes and
Cytoskeletal Proteins
To characterize the effect of C. rodentium infection on host
metabolism in vivo, we enriched IECs from colons of
C. rodentium-infected mice 8 DPI (five mice per group), when
the pathogen is shed at ca. 109 per gram of stool. IECs isolated
from uninfected mice were used as a control (five mice per
group). Examination of IECs by microscopy and flow cytometry
revealed that IEC preparations were enriched by over 90%
(Crepin et al., 2015). Immunofluorescence microscopy revealed
that IECs extracted from uninfected mice exhibited typical
columnar shape and projection of actin-rich BB microvilli.
IECs purified from mice 8 DPI were round, covered withC. rodentium associated with polymerized actin, and devoid of
microvilli (Figure 1A).
Shotgun proteomic analysis of enriched IECs, in conjunction
with isobaric labeling, allowed identification and quantification
of 7,447 unique mouse proteins at false discovery rate < 1%
(Table S4), 2,316 of which exhibited differential regulation
in infected IECs (Logpvalue>0.697, log2 fold change (Log2FC)>
0.59) (Figure 1B). Among the top proteins with higher abundance
after infection were Sglt4 (glucose transporter, Log2FC 5.11),
Abca1 (intracellular cholesterol transporter, Log2FC 4.92), and
iNOS (inducible nitric acid synthases, Log2FC 4.89).
KEGG pathway enrichment analysis of differentially regulated
proteins revealed a striking tendency toward downregulation
of pathways related to a broad range of cellular metabolic
and energy homeostasis activities including the TCA cycle,
oxidative phosphorylation, and lipid metabolism (Figure 1C).
Consistently, 53% of the downregulated proteins were mito-
chondrial (Figure 1D).
C. rodentium Inhibits Feeding of the Host TCA Cycle
Previous studies have demonstrated that C. rodentium infec-
tion results in extensive disruption of the mitochondria (Ma
et al., 2006), where ATP is produced via the TCA cycle and
oxidative phosphorylation. Key mitochondrial transporters
supplying substrates for the TCA cycle were in lower abun-
dance in infected IECs, including the pyruvate transporter
(Mpc1), the carnitine/acylcarnitine carrier (Cac), the 2-oxogluta-
rate/malate carrier (Ogcp), calcium-dependent exchanger of
cytoplasmic glutamate with mitochondrial aspartate (Aralar1/2),
and the citrate transporter (Sfxn5) (Figure 2A and quantification
in Figure S1A).
The TCA cycle is fed by multiple metabolites including a-keto-
glutarate, generated from glutamate by glutamate dehydroge-
nase and acetyl-CoA, generated via glycolysis and b-oxidation
of butyrate and other lipids (Figure 2A). Proteins involved in
b-oxidation were found in lower abundance in infected IECs (Fig-
ure S2).Moreover, the nuclear-encodedmitochondrial transcrip-
tion factor Tfam, which regulates expression of themitochondrial
b-oxidation genes (Joseph et al., 2006), was found in lower
abundance (Log2FC 0.8) and was predicted to be inactivated
(Z score: 2.333, p value: 5.14 3 105). In addition, the abun-
dance of proteins involved in butyric acid (or butanoate) meta-
bolism was also lower in infected IECs (Figure 1D), fitting with
the predicted inhibition of this pathway (Z score:3.656, p value:
5.32 3 104).
Butyrate is one of the main substrates fueling b-oxidation and
the TCA cycle in colonic IECs; importantly, the abundance of the
butyrate importer Mct1/Slc16a1 and its co-factor Bsg/CD147
was lower (Log2FC 1.4 and Log2FC 1.1, respectively) in in-
fected IECs (Figure 2B). Considering the central role butyrate
plays in energizing IECs we tested experimentally whether
C. rodentium infection inhibits butyrate uptake during in vitro
infection of polarized Caco-2 cells using [14C]sodium butyrate.
This analysis revealed a 30% reduction of butyrate uptake into
infected cells compared with uninfected control cells (Figure 2C).
Taken together, these data suggest that C. rodentium infec-
tion inhibits the supply of substrates to the TCA cycle in IECs,
which is likely to impact on downstream oxidative phosphoryla-
tion and ATP production.Cell Metabolism 26, 738–752, November 7, 2017 739
Figure 1. The Metabolic Landscape of C. rodentium-Infected IECs
(A) Immunofluorescence of IECs isolated from uninfected and infected mice 8 DPI and stained for C. rodentium (green) and actin (red). Scale bars, 5 mm.
(B) Volcano plot summarizing the differential regulation of the mouse IEC proteome during C. rodentium infection. Red, green, and gray dots represent proteins
with higher, lower, or unchanged abundance, respectively.
(C) KEGG pathway enrichment analysis; proteins in the whole proteome are ranked according to the log2 values (top panel) from the most downregulated (green)
to themost upregulated (red). Regulated proteinsmapped to significantly enriched KEGG pathways are highlighted in the heatmap (bottom panel). The pathways
are ranked from those that are highest statistical significant to the lowest (Benjamini-Hochberg false discovery rate [FDR] < 0.05).
(D) Boxplots illustrating the downregulation ofmitochondrial proteins (MSigDB annotation), proteins involved in fatty acid, b-oxidation, and butanoatemetabolism
(KEGG annotation).C. rodentium Inhibits Mitochondrial ATP Biogenesis in
Infected IECs
The TCA cycle produces NADH for oxidative phosphorylation.
The abundance of all the enzymes forming the TCA cycle and
most of the proteins in the electron transfer chain was lower
in C. rodentium-infected IECs compared with control IECs
(Figure 2D and quantification in Figure S1B). Oxidative phos-
phorylation is dependent on the inner mitochondrial membrane740 Cell Metabolism 26, 738–752, November 7, 2017lipid cardiolipin (ca. 20% of mitochondrial lipid content), which
is essential for generating the electrochemical gradient used
for ATP production (Paradies et al., 2014). Cardiolipins are syn-
thesized in the mitochondrial inner membrane by conversion
and modification of phosphatidic acid (PA), which is transferred
from the mitochondrial outer membrane by a complex
comprising Ups1/Preli and Mdm35/Triap (Miliara et al., 2015;
Yu et al., 2015).
(legend on next page)
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We found all five enzymes generating long-chain acyl-CoA
and PA in lower abundance in infected IECs (Figure S3), which
may result in accumulation of low-molecular-weight phospho-
lipids, including phosphatidylinositols (PIs), and cardiolipins.
Moreover, while Crls1, which generates immature cardiolipin,
was in higher abundance (Figure 3A and quantification in Fig-
ure S1C), the final maturation steps are likely to be impaired
due to lower abundance of the mitochondrial and cytosolic car-
diolipin maturation enzymes, Mlclat1 and Alcat1, respectively,
and the unchanged abundance of the phospholipase iPla2,
which digests monolysocardiolipin into dilysocardiolipin (Fig-
ure 3A and quantification in Figure S1C). Moreover, the abun-
dance of Mdm35/Triap was lower in infected IECs (Log2FC
0.67). Based on these observations we hypothesized that
infected cells will either accumulate low-molecular-weight cardi-
olipins or decrease the pool of cardiolipins.
By applying a lipidomics fingerprint technique to infected IECs
we were able to detect cardiolipins and PIs and to quantify their
abundance (Figure 3B). As a control, total lipid extracts from
C. rodentiumwere analyzed to confirm the specificity for eukary-
otic PIs and cardiolipins (Figure S4A). As predicted from protein
abundance measurements, low-molecular-weight PIs, present
at m/z 835.4 and 863.4 (Figure 3B), was in higher abundance in
infected IECs (Figure S4B). In addition, cardiolipins of the highest
molecular weights, present at m/z 1,570.1 and 1,598.1, were in
lower quantities in infected IECs, while cardiolipins of lower mo-
lecular weights, present at m/z 1,396.0 and 1,424.0, were in
higher abundance (Figure 3C), suggesting that accumulation
of immature mitochondrial cardiolipins disturbs oxidative phos-
phorylation during C. rodentium.
The T3SS effector Map is responsible, at least in part, for mito-
chondrial disruption in the colonic IECs (Ma et al., 2006). We
therefore reasoned that as oxygen consumption by oxidative
phosphorylation in IECs would be more efficient following infec-
tion with a map mutant (partial disruption of the mitochondria)
compared with infection with wild-type (WT) C. rodentium
(extensive disruption of the mitochondria), the apical surface of
infected IECs would be more hypoxic following infection with
the former. To test this experimentally, we infected mice with
bioluminescent WT C. rodentium or a C. rodentium map mutant
as reporters for surface oxygen concentration (as luciferase ac-
tivity is dependent on the supply of O2 to the epithelium [Ghisla
et al., 1978]). At 6 DPI both strains were shed at equal numbers
(Figure 4A). Moreover, the number of tissue-associated
C. rodentium (Figure 4B), the magnitude of CCH (Figure 4C),
and the level of Ki-67 straining, a marker of proliferating cells
(Figure 4D), were similar at 8 DPI with either the WT or the
map mutant strains. However, the bioluminescence signal was
significantly lower following infection with C. rodentium Dmap
compared with infection with WT C. rodentium (Figure 4E).
Upon complementation of the map mutant the increased biolu-Figure 2. The Effect of C. rodentium Infection on Mitochondrial Functi
(A) Schematic representation of mitochondrial transporters affected by C. roden
(B) Bar plot showing the relative abundances of the butyrate transporter Mct1 an
(C) [14C]Sodium butyrate uptake into uninfected Caco-2/TC7 cells or cells infected
represents an individual well and bars show the means.
(D) Schematic representation of the mitochondrial TCA cycle and respiratory
Figure S1B).
742 Cell Metabolism 26, 738–752, November 7, 2017minescent signal was restored (Figure 4E). These results show
that infection with WT C. rodentium results in oxygenation of
the apical surface of infected IECs independently of CCH.
C. rodentium Infection Triggers Biogenesis of
Phosphocreatine
While the proteomic and lipidomics analyses showed that the
mitochondria are dysfunctional during C. rodentium infection,
cytosolic glycolysis seems to be functioning, as key enzymes
from throughout the glycolysis pathway are either unchanged
or exhibit increased abundance during infection (Figure 5A and
quantification in Figure S1D). Moreover, the infected IECs adapt-
ed to the lack of mitochondrial ATP production by specifically
upregulating the basolateral sugar importer Sglt4 (the abun-
dance of the glucose transporter Glut1 did not change during
infection) (Figure 5A and quantification in Figure S1D).
Next, we analyzed how the glycolysis-generated ATP is effi-
ciently distributed to subcellular sites of energy utilization. One
such go-between is phosphocreatine (PCr), which is generated
by phosphorylation of creatine (Cr) by creatine kinases (CKs)
(Wallimann et al., 2011). While biogenesis of Cr (as well as orni-
thine/spermidine) is mediated via degradation of L-arginine by
Gatm, iNOS uses L-arginine as a substrate for generation of
NO. Importantly, the abundance of both Gatm and iNOS was
significantly higher in infected IECs (Figure 5B and quantification
in Figure S1E). As NO is highly bactericidal, it is possible that
C. rodentium disrupts the mitochondria as a means to shift
cellular utilization of L-arginine toward generation of Cr and
away from production of NO. This hypothesis is supported by
the fact that, based on the fold change of its target proteins,
the transcription factor Nrf2, which is activated by NO (Kvan-
dova et al., 2016), was predicted to be strongly inhibited
(Z score: 4.74, p value: 7.22 3 1010) in infected IECs.
Moreover, C. rodentium intimately colonize IECs expressing
high levels of apical iNOS (Vallance et al., 2002).
Conversion of Cr to PCr can occur in the mitochondria, by the
mitochondrial CKs Cktm1 and Cktm2, or in the cytosol via CK-m
and CK-b, which are directly associated with the glycolytic
enzymes producing ATP (Joseph et al., 1997). The abundance
of CK-m and CK-b was unchanged during infection, while the
abundance of Cktm1 and Cktm2 was lower (Figure 5B and
quantification in Figure S1E). Consistently, the inner membrane
mitochondrial ATP exporter (Ant), which is tightly coupled to
Cr phosphorylation, and the mitochondrial outer membrane
voltage-dependent anion channel (Vdac), which exports PCr
into the cytosol, were in lower abundance following infection
(Figure 2A and quantification in Figure S1A). Taken together,
this suggests that, in C. rodentium-infected IECs, L-arginine is
mainly catabolized to Cr, which is converted by cytosolic CKs
to PCr. We confirmed this experimentally using LC-MS-based
metabolomic analysis, which revealed higher levels of the Crons
tium (quantification is shown in Figure S1A).
d its co-factor Bsg during infection. Data are represented as mean ± SD.
for 2.5 hr withC. rodentium. *Mann-Whitney test with p value < 0.05. Each dot
chain with the affected proteins during infection (quantification is shown in
Figure 3. Cardiolipin Biogenesis in IECs during C. rodentium Infection
(A) Schematic representation of the regulated proteins involved in cardiolipin biogenesis (quantification is shown in Figure S1C). Proteins below the significant
value (log2 fold change >0.59 or <0.59) are shown in gray. MLCL, monolysocardiolipin; DLCL, dilysocardiolipin.
(B) MALDI-TOF mass spectra of uninfected (left panel) and infected IECs (right panel) showing the negative ion mass spectra using the DHB matrix solubilized at
10 mg/mL (mass spectra of C. rodentium are shown in Figure S4A). The absolute abundance of the ions is shown on the y axis, and the masses of the ions are
shown on the x axis. The m/z represents mass to charge ratio.
(C) Relative abundance of cardiolipins detected in uninfected and infected IECs (relative abundance of phosphatidyl inositol is shown in Figure S4B).
Mann-Whitney test with *p < 0.05. Each dot represents an individual mouse and bars geometric means.precursor guanidinoacetate (6.42 FC), Cr (2.16 FC), PCr (2.93
FC) and the breakdown produce of PCr, creatinine (2.37 FC;
Figure 5C), as well as spermidine (91.77 FC; Figure 5D),
in infected IECs.
C. rodentium Triggers Simultaneous Cholesterol
Biogenesis and Cholesterol Efflux
While a fall in the PCr:Cr ratio activates the AMP-activated
protein kinase (Ampk), a crucial cellular energy sensor (Hardie
et al., 2012), IECs infectedwithC. rodentium exhibit an increased
PCr:Cr ratio, suggesting that Ampk is not activated. Indeed,
while, the abundance of Ampk-awas similar in uninfected and in-
fected IECs, the abundance of Ampk-b andY subunits was lower
in infected cells (Figure 6A and quantification in Figure S1F).Moreover, the abundance of Lkb1, which is the main kinase
that phosphorylates and activates Ampk-a (Hardie, 2014), was
lower in infected IECs (Figure 6A and quantification in Fig-
ure S1F). Consistently, western blotting using anti-phospho
Ampk-a antibodies revealed lower levels of Ampk-a phosphory-
lation in infected cells (Figure 6B). Moreover, based on the fold
change of its target proteins, the transcription factor p53, which,
once activated by Ampk, inhibits cell proliferation (Jones et al.,
2005), is predicted to be inhibited (Z score: 4.825, p value:
2.19 3 1029). In addition, we observed increased abundance
of Acaca/b, which catalyzes the carboxylation of acetyl-CoA to
malonyl-CoA, and decreased abundance of Mlycd, which cata-
lyzes the conversion of malonyl-CoA back to acetyl-CoA (Fig-
ure 6A and quantification in Figure S1F), which goes againstCell Metabolism 26, 738–752, November 7, 2017 743
Figure 4. Infection with C. rodentium Triggers Mucosal Oxygenation
(A) C. rodentium shedding from mice infected with either bioluminescent WT (ICC180) or the isogenic Dmap mutant. Data are represented as mean ± SD.
(B) Level of mucosal-associated WT C. rodentium or C. rodentium Dmap. Data are represented as mean ± SD.
(C) WT C. rodentium and the Dmap strains trigger similar levels of CCH. Crypt measurements were taken from H&E-stained colonic sections (representative
images are shown). Scale bars, 200 mm. The graph shows measurement of individual crypt lengths. Bars represent means; *p% 0.0001.
(legend continued on next page)
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the activation of Ampk (Wolfgang and Lane, 2006). Significantly,
while Ampk inhibits cholesterol synthesis, the proteomic analysis
suggested that cholesterol biosynthesis was upregulated
(Figure 6B and quantification in Figure S1G), with most of the
enzymes driving cholesterol biogenesis found in higher abun-
dance, although DHCR7, which catalyzes the conversion of
7-dehydrocholesterol to cholesterol, was in lower abundance
(Figure 6B and quantification in Figure S1G). In agreement with
upregulation of cholesterol biosynthesis, the abundance of the
Ldl receptor (Ldl-R, Log2FC 1.31) and Pcsk9 (Log2FC 1.97),
involved in cholesterol uptake and receptor recycling, were
elevated in infected IECs. These responses are typical of cells
suffering sterol deficiency (Spann and Glass, 2013). This hypoth-
esis was supported by the fact that, based on the fold change of
its target proteins, the transcription factor Srebp2, which upre-
gulate expression of genes involved in cholesterol biosynthesis
and uptake (Spann and Glass, 2013), was predicted to be
strongly activated (Z score: 2.032, p value: 2.28 3 108) in in-
fected IECs.
Under resting conditions Srebp2 localizes to the ER, however,
sterol depletion promotes ER-to-Golgi transport of the sterol
regulator Scap together with Srebp2, where Srebp2 undergoes
proteolytic cleavage leading to nuclear translocation of its solu-
ble N terminus and subsequent expression of sterol-regulated
genes such asHmgcr and ldlR (Spann andGlass, 2013).Western
blotting of IECs purified from infected and uninfected mice
confirmed that Srebp2 was specifically cleaved and activated
during C. rodentium infection (Figure 6D).
Under Srebp2 activation conditions, processes involved in
cholesterol efflux are inhibited (Spann and Glass, 2013). Unex-
pectedly, in infected IECs we found significantly higher abun-
dance of the major basolateral cholesterol efflux transporter
Abca1 (Log2FC 4.92), as was the abundance of the cholesterol
binding protein Apoa1 (Log2FC 0.89); the apical cholesterol
heterodimeric transporter Abcg5 and Abcg8 was not found in
the proteome. We used western blotting to validate the induc-
tion of AbcA1 expression and to test whether Abcg8
is expressed in infected IECs. While Abca1 and Abcg8 were
barely detectable in control IECs, they were in higher abun-
dance in infected cells (Figure 6E). Cholesterol secreted via
Abca1/Apoa1 is excreted in feces via the reverse cholesterol
transport (via the liver) while trans-intestinal cholesterol excre-
tion is mediated by Abcg5/8 (Hong and Tontonoz, 2014). We
therefore investigated the consequences of the apparent in-
crease in cholesterol efflux by measuring its levels in feces (Fig-
ure 6F). This revealed a 67% increase in fecal cholesterol 8 DPI
(p < 0.0001).
We hypothesized that the combined elevated levels of fecal
cholesterol and mucosal oxygen would impact on the composi-
tion of the colonic mucosal-associated microbiota. Phylogenetic
analyses revealed no significant changes in alpha diversity (Fig-
ure S5), while principal-components analysis of operational
taxonomic units at the genus level showed a 70.3% separation(D) Similar levels of Ki-67 straining were observed following infection with the WT
positive cells over total crypt length. The graph shows measurement of Ki-67 sta
(E) Bioluminescence levels are lower in mice infected with the Dmap compared
indicates relative signal intensity (as photons s1 cm2 sr1). The graph shows
outline; 3.5 3 5 cm) of at least three mice per group. *t test with p value < 0.05;between infected and uninfected microbiomes (Figure 7A). In
particular, the abundance of butyrate-producing commensals
(Roseburia,Coprococcus andOdoribacter genera andmembers
of the Lachnospiraceae family) as well as Firmicutes/Bacilli and,
to a lesser extent, Firmicutes/Clostridia and Firmicutes/Erysipe-
lotrichi, was significantly reduced in infected mice (Figures 7B
and 7D), which is consistent with the oxygenation of the apical
IEC surfaces. A decline in Bacteroidetes and Tenericutes was
also observed (Figures 7B and 7E). In contrast, the facultative
aerobes Proteobacteria became the dominant phylum among
mucosal-associated bacteria during infection (Figures 7B and
7C), largely due to IEC-associated C. rodentium (Figure 7C).
Interestingly, genera not detected in uninfected mice expanded
significantly during infection (e.g., Dickeya, Cronobacter, Erwi-
nia, Klebsiella, Pantoea, Serratia, and Trabulsiella) (Figure 7C),
suggesting that, by increasing the availability of O2 and/or
cholesterol, C. rodentium infection provides a beneficial niche
for these commensal bacteria. Notably, Serratia, Dickeya, and
Erwinia have previously been described to thrive on and metab-
olize cholesterol (Caspi et al., 2016; Garcia et al., 2012).
Taken together, the apparent ‘‘confused’’ cellular behavior in
relation to cholesterol homeostasis suggests that C. rodentiuum
and the host clash over the control of cholesterol biogenesis
and efflux, which impacts on the composition of the microbiota.
DISCUSSION
Enteric bacterial pathogens and the infected host battle for con-
trol of the gut ecosystem. This battle is classically thought to
occur between the host’s innate and acquired immune systems
and counteracting bacterial virulence factors. However, the influ-
ence of infection on host cell metabolism is an underappreciated
aspect of host-pathogen interactions. In this study we employed
an unbiased quantitative shotgun proteomic screen, targeted
metabolomics, and lipidomics to define themetabolic responses
of mouse colonic IECs to C. rodentium infection, which provides
a powerful and physiologically relevant infection model (Collins
et al., 2014).
While the fact that C. rodentium infection triggers substantive
disruption of the mitochondria is well established (Ma et al.,
2006), the advantage this offers to the pathogen is unknown.
Study of bacterial interference with the mitochondria has previ-
ously focused on apoptosis (Giogha et al., 2014). In this study
we show that C. rodentium infection causes shut down of mito-
chondrial ATP production, a switch to aerobic glycolysis and
significant reduction in the levels of host high-molecular-weight
cardiolipins, lipids essential for efficient oxidative phosphoryla-
tion and maintenance of mitochondrial integrity (Ren et al.,
2014). In addition, using bioluminescent reporter strains, we
show that infection with WT C. rodentium leads to increased
oxygenation of the mucosal surface, likely due to disruption
of mitochondrial respiration. This observation is consistent with
previous work, which suggests that C. rodentium performsand the Dmap strains. Scale bars, 200 mm. The graph shows the ratio of Ki-67-
ining in individual crypt. Bars represent means; *p% 0.0001.
with those infected with the WT or complemented strains. The color scale bar
quantification of total flux (p/s) output from a defined area (white rectangular
n.s., not significant. Data are represented as mean ± SEM.
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Figure 5. C. rodentium Triggers Production of Phosphocreatine
(A) Schematic representation of the regulated proteins in the sugar import and glycolysis pathway. C. rodentium induces increased abundance of the sugar
transporter Sglt4, feeding glycolysis, which remained functional during infection (quantification is shown in Figure S1D).
(legend continued on next page)
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oxidative metabolism in vivo (Lopez et al., 2016). However, while
Lopez et al. suggested that C. rodentium triggers CCH as
a means to extract oxygen, we find that oxygenation of the
mucosal surface occurs independently of CCH. The disparity be-
tween these results is likely due to the use of a triplemap/espH/
cesF C. rodentium mutant by Lopez et al., which colonizes the
gut inefficiently. Therefore, questions remain as to the relation-
ship between CCH and oxygenation of the mucosal surface dur-
ing C. rodentium infection. Of note, oxygen availability has been
shown to be a key environmental cue for expression or activation
of the T3SS in EHEC (Carlson-Banning andSperandio, 2016) and
Shigella flexneri (Marteyn et al., 2010).
The proteomics analysis reveals that the abundance of many
plasma membrane and mitochondrial lipid and carbohydrate
transporters, which feed the TCA cycle, are significantly reduced
in infected IECs. This results in reduced butyrate uptake by IECs
infected with C. rodentium, similar to previously reported data
during EPEC infection (Borthakur et al., 2006). This observation
is consistent with the lower abundance of the butyrate importer
Mct1 and its co-factor Bsg/CD147. Moreover, the microbiome
analysis reveals reduction in the abundance of butyrate-produc-
ing commensals, which may further impact on the ability of in-
fected IECs to derive energy from luminal SCFAs. The reduction
in butyrate-producing commensals may be due to multiple fac-
tors, including C. rodentium-induced generation of antimicrobial
peptides (Collins et al., 2014) andC. rodentium-induced oxygen-
ation of the colonic mucosa, which could impact on the viability
of anaerobic members of the microbiota. Of note, Lopez et al.
(2016) found increased abundance of anaerobic commensals
(e.g., Clostridia) within the oxygenated mouse gut. The differ-
ences between the two studies are likely due to the fact that
while we quantified the abundance of mucosal-associated com-
mensals, Lopez et al. extracted DNA for microbiome analysis
form the colon content.
Importantly, while the supply of mitochondrial derived ATP
seemed to be inhibited, infected IECs do not present signs of
ATP starvation (no signs of Ampk activation). Instead, IECs adapt
to C. rodentium infection by increasing the abundance of sugar
transporters that could feed aerobic glycolysis. The transition
from oxidative phosphorylation to glycolysis is reminiscent of
cancer cells and of classically activated macrophages (M1),
which rely on aerobic glycolysis for energy, a phenomenon
known as the ‘‘Warburg effect’’ (Koppenol et al., 2011). Notably,
the fact that inhibition of glycolysis in transformed cells can
re-activate oxidative phosphorylation suggests that the mito-
chondria in these cells are not damaged (Fantin et al., 2006). In
contrast, C. rodentium disrupts the structure of IEC mitochon-
dria, likely locking infected cells in aerobic glycolysis and forcing
them to produce creatine.
Coupled with the aerobic glycolytic program, the abundance
of enzymes involved in L-arginine degradation, which leads to
biosynthesis of Cr/PCr and spermidine was higher in infected(B) Schematic representation of the regulated proteins in the phosphocreatine p
phosphocreatine (quantification is shown in Figure S1E).
(C) Relative abundance of creatine and creatine derivatives detected in uninfected
an individual mouse and bars show the geometric means. *Mann-Whitney test w
(D) Relative abundance of spermidine detected in uninfected and infected IECs. E
*Mann-Whitney test with p value < 0.05.IECs. We confirmed experimentally the presence of elevated
levels of these metabolites. Although we detected a ca. 100-
fold increase in the level of spermidine in infected IECs, we are
unable to conclude that this is due solely to increase spermidine
production by infected IECs, as spermidine can also be gener-
ated by C. rodentium and the commensal flora. Importantly, in
addition to being a substrate for Cr biogenesis, L-arginine
is also used by iNOS, the protein with the sixth highest FC
in response to infection. The inflammatory responses to
C. rodentium infection leads to robust decoration of the apical
surface of IECs with iNOS (Vallance et al., 2002); yet, although
sensitive to NO (Vallance et al., 2002), C. rodentium thrives while
forming intimate attachments with the plasma membrane of
IECs. We therefore suggest that by triggering disruption of the
mitochondria C. rodentium forces IECs to tilt the balance away
from iNOS and NO production toward Gatm and Cr and poly-
amines, which themselves inhibit iNOS (Southan et al., 1994).
This rebalancing may represent an immune evasion strategy.
Importantly, at 14 DPI the abundance of Gatm returned to the
pre-infection level, while the abundance of iNOS remained at
the level seen 8 DPI, which could potentially contribute to
C. rodentium clearance. Indeed, iNOS-deficient mice display a
small but significant delay in bacterial clearance (Vallance
et al., 2002). To the best our knowledge, our study is first to
show that such an evasion strategy might occur in vivo in IECs.
Previous studies have demonstrated that, while infecting the
macrophage cell line RAW264.7 in vitro, Salmonella typhimurium
upregulates expression of Arg2 to divert arginine away from
iNOS (Lahiri et al., 2008). While we detected lower abundance
of both Arg1 and Arg2 in IECs duringC. rodentium infection, sub-
version of substrates from iNOSmight be a commonmechanism
of innate immune evasion by pathogenic bacteria.
While lipid biogenesis in general was downregulated in in-
fected IECs, one of the most conspicuous consequences of
C. rodentium infection was activation of Srebp2 and choles-
terol biogenesis, despite the high-energy cost involved. More-
over, although seeming to be in limited supply, the available
acetyl-CoA appeared to be diverted to cholesterol biogenesis.
This is the first time the cholesterol biosynthetic pathway has
been shown to be induced in IECs response to an enteric
infection.
Our current understanding of the function cholesterol plays in
innate immunity mainly comes from studies of macrophages,
where a positive feedback loop augments inflammatory re-
sponses. Macrophages containing elevated levels of choles-
terol, e.g., in abca1 knockdown cells or in hypercholesterolemia
not only contain higher levels of TLR4 and TLR9, but are also hy-
per-responsive to lipopolysaccharide as well as to TLR2, TLR7,
and TLR9 agonists (Tall and Yvan-Charvet, 2015). As TLR
signaling, e.g., IL-6 or TNF-a, triggers activation of Srebp2 (Gie-
rens et al., 2000) and decreases cholesterol efflux, the choles-
terol content of lipid rafts increases, which further amplifiesathway. L-Arginine is diverted toward production of spermidine, creatine, and
and infected IECs. Mann-Whitney test with p value < 0.05. Each dot represents
ith p value < 0.05.
ach dot represents an individual mouse and bars show the geometric means.
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Figure 6. C. rodentium Triggers Production and Secretion of Cholesterol
(A) Schematic representation of the Ampk-regulated proteins and downstream pathways, suggesting that Ampk is inactive. The transcription factor TP53 was
predicted to be inhibited (blue), whereas Srebp2 was predicted activated (orange), promoting cell-cycle and cholesterol biosynthesis, respectively (quantification
is shown in Figure S1F).
(B) Phosphorylation of Ampka in control and infected IECs.
(C) Schematic representation of the regulated proteins in the cholesterol biosynthetic pathway showing a global increased of enzyme abundance (quantification is
shown in Figure S1G). Proteins below the significant value (log2 fold change >0.59 or <0.59) are shown in gray.
(D) Western blot of Srebp2 and Gapdh on uninfected and infected IECs showing that Srebp2 (full arrowhead) is cleaved and activated in infected cells (open
arrowhead). A pool of three mice was used for the western blot.
(E) Western blots of Abca1 and Abcg8 in uninfected and C. rodentium-infected IECs.
(F) Level of fecal cholesterol measured in uninfected and infectedmice. *Mann-Whitney test with p value < 0.05. Each dot represents an individual mouse and bars
show the geometric means.activation of TLRs and NF-kB signaling (Tall and Yvan-Charvet,
2015). Although no equivalent data are available for IECs, activa-
tion of the cholesterol biosynthetic pathway may represent
an important arm of the innate immune response to bacterial
infection at mucosal surfaces. Indeed, the TLR adaptor,
MyD88, is essential for host survival and optimal immunity748 Cell Metabolism 26, 738–752, November 7, 2017following C. rodentium infection (Collins et al., 2014). Moreover,
C. rodentium infection triggers rapid NF-kBnuclear translocation
and robust recruitment of macrophages and neutrophils, which
is diminished in TLR4-deficient mice. In addition, TLR2/
mice succumb to C. rodentium infection (Collins et al., 2014).
Consistent with this, a large proportion of the C. rodentium
Figure 7. Impact of C. rodentium on the Tissue-Associated Microbiota
(A) Three-dimensional principal-components analysis (PCA) of tissue-associated microbiota at the genus level (observed species are shown in Figure S5).
(B) Relative abundance (average) of the different phyla found in tissue-associated microbiota; *Mann-Whitney test with p value < 0.05.
(C–E) Proteobacteria (C), Firmicutes (D), and Bacteroidetes and Tenericutes (E) genus abundances of tissue-associated microbiota. All data in (C–E) have a
p value < 0.05 (Mann-Whitney test with FDR corrected). Each dot represents individual mouse and bars show the means.T3SS effectors are dedicated to dampening these innate im-
mune processes (Pallett et al., 2017; Pearson et al., 2016).
Unexpectedly, alongside activation of cholesterol biosyn-
thesis the cholesterol efflux transporters Abca1 and Abcg8
were also present at higher abundance in infected IECs. These
transporters are likely functional, as significantly higher level of
fecal cholesterol was detected in C. rodentium-infected mice.
A previous study reported elevated levels of serum cholesterol
during C. rodentium infection, although the reason for this was
not apparent (Raczynski et al., 2012). Our study suggests that
cholesterol efflux from IECs can reach the lumen of the gut via
reverse cholesterol transport. Notably, increased fecal choles-
terol was associatedwith a bloomof the colonic commensalSer-
ratia, Dickeya, and Erwinia, which can metabolize cholesterol
(Caspi et al., 2016; Garcia et al., 2012), and therefore benefit
from the alteration of the gut niche which occurs as a conse-
quence of C. rodentium (IEC interaction).
Under physiological conditions cholesterol limitation actives
Srebp2 leading to cholesterol biogenesis and uptake, while an
excess of cholesterol, which is cytotoxic, triggers expression
of Abca1, Abcg5/8, and cholesterol efflux via the transcription
regulator liver X receptor (Hong and Tontonoz, 2014). Using
western blotting we found low levels of Abca1 and Abcg8 inIECs isolated from uninfected mice and robust expression
in infected cells. Therefore, during C. rodentium infection both
cholesterol biosynthesis and efflux are operating simulta-
neously. Importantly, at 14DPI the abundance of the rate-limiting
enzyme in the cholesterol biosynthetic pathway (hydroxymethyl-
glutaryl-CoA reductase, Hmgcr) as well as Abca1, returned to
pre-infection levels. Our data suggest that, while cholesterol
biogenesis appears to be an innate immune IEC response to
infection, the increased abundance of Abca1, Abcg5/8, ApoA1,
and cholesterol efflux, concomitant with cholesterol production
could represent yet another layer of defenseC. rodentium erects
while battling host immunity.
Taken together our data suggest that C. rodentium subverts
metabolism in IECs to evade immune responses and change
the oxygen availability at the apical surface of IECs. As IECs
adapt to C. rodentium-induced disruption of the mitochondria
by increasing glucose uptake, feeding glycolysis, and dissemi-
nating ATP via PCr, L-arginine is diverted from iNOS andNO pro-
duction. Moreover, C. rodentium infection appears to dampen
TLR4 signaling by triggering cholesterol efflux. As controlling
the cholesterol circuit involves the pathogen, IECs, and inflam-
mation, this phenotype has not been observed, or could not be
easily studied, in cell culture models. Indeed, infection ofCell Metabolism 26, 738–752, November 7, 2017 749
Caco-2 cells with EPEC impacts on central metabolism but does
not induce the cholesterol biosynthetic pathway (Hardwidge
et al., 2004).
Our data suggest that subversion of the central carbon meta-
bolism in IECs is an important infection strategy, which is likely to
be shared between C. rodentium and human pathogens. There-
fore, our findings could open the way for development of new
intervention strategies, either directly applied to the host, or indi-
rectly via microbiome-based metabolite treatment (Suez and Eli-
nav, 2017).
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Ki-67, rabbit monoclonal antibody (Clone SP6) ThermoFisher Scientific Cat# RM-9106-F0; RRID: AB_721371
E-Cadherin, purified mouse antibody (Clone 36) BD Transduction Laboratories Cat# 610182; RRID: AB_397581
Intimin b, purified chicken antibody IgY John Morris Fairbrother – (Mundy
et al., 2007)
N/A
O152, Rabbit Polyclonal Antibody Claire Jenkins, Public Health
England –(Schiering et al., 2017)
N/A
Phospho-AMPKa (Thr172), purified rabbit
monoclonal antibody (Clone 40H9)
Cell Signaling Technology Cat# 2535; RRID: AB_331250
Gapdh, rabbit polyclonal antibody Abcam Cat# ab9485; RRID: AB_307275
Srebp2, rabbit polyclonal antibody Abcam Cat# ab30682; RRID: AB_779079
Abca1, mouse monoclonal antibody (clone AB.H10) Abcam Cat# ab18180; RRID: AB_444302
Abcg8, rabbit polyclonal antibody Abcam Cat# ab126493; RRID: AB_11130138
Cy3 AffiniPure Goat Anti-Chicken IgY (IgG) (H+L) Jackson ImmunoResearch Cat# 103-005-155; RRID: AB_2337379
AMCA AffiniPure Donkey Anti-Mouse IgG (H+L) Jackson ImmunoResearch Cat# 715-155-150; RRID: AB_2340806
Alexa Fluor 488 AffiniPure Donkey
Anti-Rabbit IgG (H+L)
Jackson ImmunoResearch Cat# 711-545-152; RRID: AB_2313584
Peroxidase AffiniPure Goat Anti-Rabbit
IgG, Fc fragment specific
Jackson ImmunoResearch Cat# 111-035-008; RRID: AB_2337937
Peroxidase AffiniPure Goat Anti-Mouse
IgG, Fcg fragment specific
Jackson ImmunoResearch Cat# 115-035-008; RRID: AB_2313585
Bacterial and Virus Strains
Wild type C. rodentium Pr. Frankel, (Schauer and
Falkow, 1993)
ICC169
C. rodentium ICC169::Lux Pr. Frankel, (Wiles et al., 2004) ICC180
C. rodentium ICC180 Dmap This study ICC1411
C. rodentium ICC180 Dmap::map This study ICC1412
pSEVA612S-map Pr. Frankel, Imperial College pICC2536
pSEVA612S-HR Pr. Frankel, Imperial College pICC2537
pACBSR Ruano-Gallego et al., 2015 N/A
pRK2013 Figurski and Helinski, 1979 N/A
Chemicals, Peptides, and Recombinant Proteins
Phalloidin–Tetramethylrhodamine B isothiocyanate Sigma-Aldrich P1951-.1MG
C14 -Sodium butyrate American Radiochemicals Inc. ARC 0191-250
Critical Commercial Assays
Total Cholesterol Assay Kits Cambridge bioscience STA-384
Deposited Data
Mass spectrometry proteomics data ProteomeXchange Consortium
(PRIDE)
PXD005004
Experimental Models: Cell Lines
Caco-2 - TC7 clone (male) Pr. Imad Kansau (Universite
Paris Sud)
N/A
Experimental Models: Organisms/Strains
Pathogen-free female C57BL/6 mice Charles River, UK Strain Code: 027
Pathogen-free female C3H/HeNCrl mice Charles River, UK Strain Code: 025
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Oligonucleotides
TACTGCATGCTGTGCAAGATCTGTGAGAAA
TTGTTCATTCAT
Pr. Frankel, Imperial College DC074
TACTGAGCTCTTTATATTGTTATGATGCAA
CGGTATGCAGTC
Pr. Frankel, Imperial College DC075
ATAGAAAAAACATACCAAGCATTTCTCGGT Pr. Frankel, Imperial College DC084
CAGGGGAGAAAATAATAAACGAGATCC Pr. Frankel, Imperial College DC085
Software and Algorithms
Ingenuity Pathway Analysis (IPA) Qiagen https://www.qiagen.com/dk/products/life-
science-research/research-applications/
gene-expression-analysis/analysis/ingenuity-
pathway-analysis/
Living Image Software 4.3.1 Perkin Elmer http://www.perkinelmer.co.uk/product/
lumina-kinetic-xr-100-living-image-v4se-128110
Proteome Discoverer Software ThermoFisher Scientific https://www.thermofisher.com/order/
catalog/product/IQLAAEGABSFAKJMAUH
Perseus 1.4 Max Planck Institute of Biochemistry http://www.coxdocs.org/doku.php?id=
perseus:start
QIIME (Caporaso et al., 2010) http://qiime.org/
Data Explorer 4.9 Applied Biosystems N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gad
Frankel (g.frankel@imperial.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial Strain
C. rodentium strains listed in Table S1 were grown at 37C in Luria–Bertani (LB) with necessary antibiotics as indicated in Tables S1
and S2 at the following concentrations: nalidixic acid (50 mg/ml), kanamycin (50 mg/ml), streptomycin (50 mg/ml) or gentamicin
(10 mg/ml).
Animals
All animal experiments were performed in accordance with the Animals Scientific Procedures Act 1986 and were approved by the
local Ethical Review Committee and UK Home office guidelines. Experiments were designed in agreement with the ARRIVE guide-
lines (Kilkenny et al., 2010), for the reporting and execution of animal experiments, including sample randomization and blinding.
Pathogen-free female C57BL/6 mice (18 to 20 g) or C3H/HeNCrl mice (18 to 24 g) were purchased from Charles River, UK. All
mice were housed in individually HEPA-filtered cages with sterile bedding (Processed corncobs grade 6), nesting (LBS Serving
technology) and free access to sterilized food (LBS Serving technology) and water. A minimum of 4 and a maximum of 8 mice
randomly assigned for each group were used per experiment. Each experiment was repeated a minimum of two times.
Cell Culture
Human (male) epithelial colorectal adenocarcinoma cells (Caco-2), clone TC-7 were maintained in DMEMwith glucose (1g/L; Sigma)
supplemented with 20% (v/v) FCS (Gibco), 2 mM Glutamax (Sigma) and 0.1 mM non-essential amino acids (NEAA) (Sigma) and
incubated at 37C, 10% CO2.
METHOD DETAILS
Generation of C. rodentium Map Mutant
All plasmids and primers used are listed in Tables S2 and S3, respectively. The map flanking regions were synthetized by GeneArt
(ThermoFisher) and sub-cloned into pSEVA612S vector. Alternatively, map and its flanking regions were PCR amplified (primer
DC074 and DC075) from purified C. rodentium genomic DNA. The PCR amplicon was purify using a PCR purification kit (Qiagen),
digested in CutSmart buffer at 37C for 2 hours with the High Fidelity Enzymes SacI and SphI (New England Biolabs) and ligatede2 Cell Metabolism 26, 738–752.e1–e6, November 7, 2017
into pSEVA612S vector using T4 Ligase (New Engand Biolabs) for 2 hours at room temperature. The pSEVA612 derivatives were then
chemically transformed in CC118lpir E. coli (Herrero et al., 1990).
The map gene was deleted from C. rodentium ICC180 pre-transformed with pACBSR – a plasmid containing the endonuclease
I-SceI (Ruano-Gallego et al., 2015), using tri-parental conjugation. Donor strain (E. coliCC118lpir containing pSEVA612 derivatives),
helper strain (E. coli CC1047 (Kaniga et al., 1991), containing pRK2013 (Figurski and Helinski, 1979)), and ICC180-pACBSR were
combined and grown for at least 6 h prior to overnight selection on LB agar supplemented with gentamicin and spectinomycin.
Selected colonies were grown in LB broth supplemented with and L-arabinose (0.4%) for a minimum of 6 h, to induce the I-SceI
endonuclease from pACBSR plasmid. Cultures were subsequently streaked out for overnight growth on LB spectinomycin. Colonies
were screened by PCR for successfulmap deletion, using primers DC084 and DC085. The samemethod was used for re-insertion of
map onto the genome. C. rodentium strains were sequenced (GATC Biotech) to confirm deletion and re-insertion of map.
Oral Gavage of Mice and CFU Count
Mice were inoculated by oral gavage with 200 ml of overnight LB-grown C. rodentium suspension 10X concentrated in PBS (5 x109
colony forming units (cfu)). Uninfected mice were mock treated with PBS (200 ml). The number of viable bacteria used as inoculum
was determined by retrospective plating onto LB agar containing nalidixic acid. Stool samples were recovered at regular intervals
after inoculation and the number of viable bacteria per gram of stool was determined by plating onto LB agar containing nalidixic
acid. For determining tissue associated CFU, 4 cm of distal colonic tissues were harvested, opened longitudinally to allow stools
removals, washed in PBS and homogenized in 10ml PBS per gram of tissue using an gentleMACs automated tissue dissociator (Mil-
tenyi Biotech). The aqueous layer was plated on LB agar containing nalidixic acid and the CFU were quantified.
Extraction of Enterocytes
At 8 DPI, 4-cm segment of terminal colon was cut longitudinally, placed in 4 ml enterocyte dissociation buffer (1X Hanks’ balanced
salt solution without Mg and Ca, containing 10 mM HEPES, 1 mM EDTA and 5 ml/ml 2-b-mercaptoethanol), and incubated at 37C
with shaking, for 45 min. The enterocytes were collected by centrifugation (2,000 x g for 10 min) followed by two PBS washes.
Enterocytes pellets were either kept frozen for proteomic analysis and Western blotting or fixed in 4% formaldehyde for immunoflu-
orescence staining.
Immunostaining of IECs
Fixed enterocytes were permeabilized with 0.1% Triton and stained with rabbit polyclonal anti O152 antiserum (a gift from Claire
Jenkins, Public Health England) for 20 min, followed by 30 min of incubation with standard secondary as described above and
with Phalloidin-TRITC (Sigma) to visualize actin filament. Samples were analyzed with an Axio Imager M1 microscope (Carl Zeiss
MicroImaging GmbH, Germany), and images were acquired using an AxioCamMRmmonochrome camera and computer processed
using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).
Tissue Staining and CCH Measurement
Half a centimeter of terminal colon of each mouse was collected, flushed with PBS and fixed in 1 ml 10% neutral buffered formalin.
Formalin fixed tissues were then processed, paraffin-embedded and sectioned at 5mm. Paraffin-embedded sections (FFPE) were
either stained with haematoxylin and eosin (H&E) using standard techniques or treated with sodium citrate antigen de-masking so-
lution prior to immunofluorescence. Primary antibodies were used at 1:200 dilution for anti-intimin (a gift from Professor Fairbrother,
Montreal University) and 1:50 for E-cadherin (CD324; BD Biosciences) and Ki67 (SP6; Thermo Scientific) followed by secondary an-
tibodies from Jackson ImmunoResearch used at a 1:200 dilution (donkey anti chicken Cy3, donkey anti mouse AMCA, donkey anti
rabbit – AlexaFluor 488). H&E stained tissues were evaluated blindly for CCH microscopically by measuring the length of at least
20well-oriented crypts from each section from all of themice per treatment group. Similarly, Ki-67 staining was assessedmicroscop-
ically by measuring the distance from the bottom of the crypt to the last stained nuclei. For comparison, Ki-67staining was expressed
as a ratio over the total length of the crypt. Tissues were imaged with an Axio, images were acquired using an Axio camera, and com-
puter-processed using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).
Bioluminescence Imaging
For bioluminescent imaging (BLI), C3H/HeNCrl mice were depilated using hair removal cream (Veet) prior to infection to remove pig-
mented fur that may interfere with signal output. At 6 DPI, animals were imaged using the IVIS Spectrum CT (Perkin Elmer) system
under gaseous anesthesia with isofluorane (Zoetis).
Fecal Cholesterol Measurement
Total fecal cholesterol (cholesterol esters and free cholesterol) was quantified using a colorimetric reaction, as per manufacturer rec-
ommendations (Cell Biolabs, STA-384). Stools were harvested from uninfected and infected mice 8 DPI, vacuum dried and weighed
before being crunched to powder and extracted in 800 ml of a mixture of chloroform : isopropanol : NP-40 (7:11:0.1). The colorimetric
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Immunoblotting
Proteins were resolved by SDS-PAGE, and gels were transferred to polyvinylidene difluoride membrane (GE Healthcare). Mem-
branes were washed with TBS 0.2% Tween, blocked in TBS supplemented with 0.2% Tween, 3% BSA and 0.5% gelatin for
30 min at room temperature and probed with specific antibodies overnight at 4C. After three washes of 10 min in TBS 0.2% Tween,
blots were incubated with horseradish peroxidase-linked secondary antibody (Jackson ImmunoResearch) for 45 min at room tem-
perature, followed by EZ-ECL assay, according to the manufacturer’s instructions (Biological Industries). Chemiluminescence was
detected using a Chemidoc (BioRad). Primary antibodies used were: anti-Srebp2 (ab30682; Abcam), p-AMPKa (#2535; cell
signaling), Abca1 (ab18180; Abcam), Abcg8 (ab126493; Abcam) and anti-Gapdh (ab9485; Abcam).
[1-14C] Sodium Butyrate Uptake Assay
Caco-2/TC-7 cells were seeded at 3.5x104 in 1 ml of media in triplicate in 24-well plates 12-14 days prior to the experiment and the
media replaced every 48 hours. 4. Caco-2 media was changed for serum free media the night before infection (1g/L glucose DMEM
with NEAA and glutamax). The day before the experiment, C. rodentium was grown for eight hours during the day in LB, before dilu-
tion 1:100 in DMEM (1g/L glucose) (no supplements) and incubation over night at 37C, 10% CO2. The morning of the infection,
C. rodentium cultures were diluted 1:10 into fresh DMEM andCaco-2’s infected with 5x107 bacteria per well. Plates were centrifuged
at 100 xg for 5 minutes to synchronize infections before incubation for 2.5 hours. After infection, cells were washed 1 x PBS and incu-
bated in HBSS supplemented with 1.3 mMCaCl2, 5.4 mMKCl, 0.44 mMK2HPO4, 0.4 mMMgSO4, 0.4 mMNa2HPO4, 4mMNaHCO3,
0.5 mMMgCl2, 135 mM choline chloride, and 10mMHEPES pH 7.5 for 15 minutes. Cells were washed 1 x HBSS pH 6.5 and 0.2 mM
[1-14C] Sodium Butyrate (American Radiochemicals Inc.) added for 5 minutes. After incubation, cells were washed 3 x ice cold HBSS
pH 6.5 before solubilisation in 0.1 M NaOH/0.1% SDS for 4 hours at 37C. Protein concentration was measured using a BCA assay
(Pierce) and incorporated radioactivity was counted using a Wallac 1409 DSA liquid scintillation counter, in conjunction with Ultima
Gold scintillation fluid (Perkin Elmer).
Sample Preparation for TMT Labelling
IEC pellets, isolated from C. rodentium infected and uninfected mice, were dissolved in 100 mL 0.1 M triethylammonium bicarbonate
(TEAB), 0.1% SDS assisted with pulsed probe sonication. Protein concentration was measured with Quick Start Bradford Protein
Assay (Bio-Rad) according tomanufacturer’s instructions. Aliquots containing 100 mg of total protein were prepared for trypsin diges-
tion. Samples were reducedwith tris-2-carboxymethyl phosphine (TCEP) and alkylated with Iodoacetamide (IAA), followed by trypsin
digest as described above. The resultant peptides were diluted up to 100 mL with 0.1 M TEAB buffer and labelled with TMT 10-plex
reagent vial (Thermo Scientific) according to manufactures instructions.
Basic Reverse-Phase Peptide Fractionation
Offline peptide fractionation based on high pH Reverse Phase (RP) chromatography was performed using the Waters, XBridge C18
column (2.1 x 150 mm, 3.5 mm, 120 A˚) on a Dionex Ultimate 3000 HPLC system equipped with an auto sampler. Mobile phase A was
composed of 0.1% ammonium hydroxide andmobile phase Bwas composed of 100%acetonitrile, 0.1% ammonium hydroxide. The
TMT labelled peptide mixture was reconstituted in 100 mL mobile phase A, for fractionation using a multi-step gradient elution
method at 0.2 mL/min as follows: for 5 minutes isocratic at 5% B, for 35 min gradient to 35% B, gradient to 80% B in 5 min, isocratic
for 5 minutes and re-equilibration to 5% B. Fractions were collected in a time dependent manner every 30 sec and dried.
LC-ESI-MS/MS Analysis
LC-MS analysis was performed on the Dionex Ultimate 3000 UHPLC system coupled with the Orbitrap Fusion Tribrid Mass Spec-
trometer (Thermo Scientific). Each peptide fraction was reconstituted in 40 mL 0.1% formic acid and a volume of 7 mL was loaded to
the Acclaim PepMap 100, 100 mm 3 2 cm C18, 5 mm, 100 A˚ trapping column with the mlPickUp mode at 10 mL/min flow rate. The
sample was then subjected to amulti-step gradient elution on the Acclaim PepMap RSLC (75 mm3 50 cm, 2 mm, 100 E) C18 capillary
column (Dionex) retrofitted to an electrospray emitter (NewObjective, FS360-20-10-D-20) at 45 C.Mobile phase Awas composed of
100% H2O, 0.1% formic acid and mobile phase B was composed of 80% acetonitrile, 0.1% formic acid. The gradient separation
method at flow rate 300 nL/min was as follows: for 95 min gradient to 42% B, for 5 min up to 95% B, for 8 min isocratic at 95%
B, re-equilibration to 5% B in 2 min, for 10 min isocratic at 5% B. Precursors between 400-1500 m/z were selected with mass res-
olution of 120 k, AGC 33105 and IT 100mswith the top speedmode in 3 sec andwere isolated for CID fragmentation with quadrupole
isolation width 0.7 Th. Collision energy was set at 35%with AGC 13104 and IT 35ms. MS3 quantification spectra were acquired with
further HCD fragmentation of the top 10 most abundant CID fragments isolated with Synchronous Precursor Selection (SPS)
excluding neutral losses of maximum m/z 30. Quadrupole isolation width was set at 0.5 Th, collision energy was applied at 45%
and the AGC setting was at 63104 with 100ms IT. The HCD MS3 spectra were acquired only for the mass range 120-140 with
60k resolution. Targeted precursors were dynamically excluded for further isolation and activation for 45 seconds with 7 ppm
mass tolerance.
Database Search and Protein Quantification
The acquired mass spectra were submitted to the SequestHT search engine implemented in the Proteome Discoverer 2.1 (Thermo
Scientific) software for protein identification and quantification. The precursormass tolerancewas set at 20 ppm and the fragment ione4 Cell Metabolism 26, 738–752.e1–e6, November 7, 2017
mass tolerance was set at 0.5 Da. Spectra were searched for fully tryptic peptides with maximum 2 miss-cleavages and minimum
length of 6 amino acids. TMT6plex at N-terminus, K and Carbamidomethyl at C were defined as static modifications. Dynamic mod-
ifications included oxidation of M and Deamidation of N, Q. Amaximum of two different dynamicmodifications were allowed for each
peptide. Peptide confidence was estimated with the Percolator node. Peptide FDR was set at 0.01 and validation was based on
p-value and decoy database search. All spectra were searched against a fasta files containing the UniProt Reference Proteomes
of 16,608 mouse reviewed protein entries. The reporter ion quantifier node included a custom TMT 10plex quantification method
with an integration window tolerance of 15 ppm and integration method based on the most confident centroid peak at the MS3 level.
Only unique peptides were used for quantification, considering protein groups for peptide uniqueness. Peptides with average
reported S/N>3 were used for protein quantification. The enterocytes obtained from uninfected mice were used as controls for
log2 ratio calculations. Differential expression p-values were computed based on a single-sample t-test using the Perseus prote-
omics tool and the average protein log2 ratios from the two measurements in each time point were used for downstream analyses.
Specificity thresholds used for the analysis were defined as log p-value > 0.697 and log2 ratio > 0.59 or < -0.59 (equivalent to 1.5 fold
change).
Bioinformatics Analysis
Differential protein abundance p-values were computed based on one-sample t-test using the Perseus 1.4 software (Tyanova et al.,
2016) and the respective volcano plot was drawn in R using the ggplot2 package. KEGGpathway enrichment analysis was performed
in Perseus 1.4 software (Tyanova et al., 2016) with the 1D-annotation enrichment method (Cox and Mann, 2012). The enrichment
score indicates whether the proteins in a given pathway tend to be systematically up-regulated (positive score) or down-regulated
(negative score) based on a Wilcoxon-Mann-Whitney test. Significantly enriched KEGG pathways were filtered for Benjamini-Hoch-
berg FDR<0.05.
Specifically regulated protein 8 DPI were upload in Ingenuity Pathway Analysis (IPA) (Qiagen) platform which provides a compre-
hensive knowledgebase of curated experimentally observed annotations aswell as reviewed findings from third party resources. Sta-
tistically significant over-representation of canonical pathways, cellular and molecular functions and enrichment of upstream regu-
lators were calculated using the right-tailed Fisher Exact Test. The Benjamini-Hochberg method was used for multiple testing
corrections (p<0.05). Trends of activation/inhibition states of the enriched functions and regulators were inferred by the calculation
of a z-score (-2 < z-score > 2). IPA was used for construction and visualization of interaction networks using experimentally observed
relationships that included direct or indirect interactions.
Lipid Fingerprint by MALDI-TOF MS
Isolated IECs or bacterial culture were washed three times with 0.5 ml of double distilled water at 15,000xg for 5 min and the super-
natant was discard. The pellet was suspended in double distilled water. Prior to mass spectrometry analysis, the 2, 5-dihydroxyben-
zoic acid (DHB) matrix was used at a concentration of 10 mg/ml in chloroform/methanol 90:10 v/v. 0.4 ml of biological sample and
0.8 ml of the matrix solution were deposited on the target, mixed with a micropipette and dried under a gentle stream of air.
MALDI-TOF MS Analysis
MALDI-TOF MS analysis was performed on a 4800 Proteomics Analyzer (with TOF-TOF Optics, Applied Biosystems) using the
reflectron mode. Samples were analyzed operating at 20 kV in the negative ion mode using an extraction delay time set at 20 ns.
Typically, spectra from 500 to 2,000 laser shots were summed to obtain the final spectrum. All experiments were carried out in three
independent biological repeats. Mass spectrometry data were analyzed using Data Explorer version 4.9 from Applied Biosystems.
Targeted Metabolomics of IECs
Isolated IECs were suspended in PBS and metabolically quenched by addition of acetonitrile/methanol/H2O (2:2:1) on ice. Metab-
olites were extracted by mechanical lysing with a micropipette. Lysates were clarified by centrifugation and filtered through 0.22 mm
Spin-X column filters (Costar). Biomass of individual samples was determined by measuring the residual protein content of the
metabolite extracts using the BCA assays kit (Thermo). Aqueous normal phase liquid chromatography was performed using an Agi-
lent 1290 Infinity II LC system equipped with a binary pump, temperature-controlled auto-sampler (set at 4C) and temperature-
controlled column compartment (set at 25C), containing a Cogent Diamond Hydride Type C silica column (150 mm 3 2.1 mm;
dead volume 315 ml). A flow-rate of 0.4 ml/min was used. Elution of polar metabolites was carried out using solvent A consisting
of deionized water (Resistivity 18 MU cm), 0.2% acetic acid and solvent B consisting of acetonitrile and 0.2% acetic acid in aceto-
nitrile. The following gradient was used: 0 min 85% B; 0-2 min 85% B; 3-5 min to 80% B; 6-7 min 75% B; 8-9 min 70% B; 10-11 min
50% B; 11.1-14 min 20% B; 14.1-25 min hold 20% B follow by a 5 min re-equilibration period in 85% B at a flow-rate of 0.4 ml/min.
Accurate mass spectrometry was carried out using an Agilent Accurate Mass 6545 QTOF apparatus. Dynamic mass axis calibration
was achieved by continuous infusion, post-chromatography, of a reference mass solution using an isocratic pump connected to an
ESI ionization source, operated in the positive-ion mode. Nozzle Voltage and fragmentor voltages were set at 2,000 V and 100 V,
respectively. The nebulizer pressure was set at 50 psi and the nitrogen drying gas flow rate was set at 5 l/min. The drying gas tem-
perature was maintained at 300C. The MS acquisition rate was 1.5 spectra/sec and m/z data ranging from 50-1,200 were stored.
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resolution ranging from 10,000-25,000 over the m/z range of 121-955 atomic mass units, and a 100,000-fold dynamic range with
picomolar sensitivity. The data were collected in the centroid mode in the 4 GHz (extended dynamic range) mode.
16S rRNA Gene Sequencing
Colons were collected frommice and DNA was isolated using PowerSoil DNA Isolation Kit (MO BIO Laboratories). For 16S amplicon
pyrosequencing, PCR amplification was performed spanning the V3and V4 region using the primers 515F/806R of the 16S rRNA
gene and subsequently sequenced using 500bp paired-end sequencing (Illumina MiSeq). Reads were then processed using the
QIIME (quantitative insights into microbial ecology) analysis pipeline with USEARCH against the Greengenes database. Importantly,
the C. rodentium 16SRNA sequence was recognized by the Greengene database as Enterobacter, as the two differ in only 8 bp
(hence the combined classification in Figure 7C).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis
GraphPad Prism software was used for all statistical calculations. Statistical test used was Mann-Whitney compared to controls
(or as indicated in the figure). P-values < 0.05 were considered significant. For the microbiota, p-values were FDR corrected using
Benjamini and Hochberg method.
Quantification of BLI and Statistical Analyses
Analysis of IVIS Spectrum images was carried out on Living image software. Photons from regions of interest (ROI) of a defined size
(3.5 x 5cm)were quantified as total photon flux (p/s). All statistical analysis was carried out usingGraphPadPrism 7.0. Amultiple t-test
was used to identify statistical significance for total flux output of bioluminescent images.
DATA AND SOFTWARE AVAILABILITY
Themass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identifier PXD005004.e6 Cell Metabolism 26, 738–752.e1–e6, November 7, 2017
